Inducible silencing of either SOX9 or TCF7L2 potently increased apoptosis and decreased proliferation, resulting in suppression of tumor growth of the SOX9‐TCF7L2 double‐high GBC model in vivo (Figure 3F–H; Figure S5J, Supporting Information). The gene discussed is SOX9; the disease is neoplasm.